Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

Key Inclusion Criteria:

• Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification);

• Subject must be able to understand and sign an approved informed consent form;

• Subject is willing to complete all the required study visits for the duration of thestudy;

• Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

• Ocular conditions as specified in the protocol;

• Subjects who desire monovision correction;

• Previous intraocular or corneal surgery;

• Other protocol-defined exclusion criteria may apply.